Next-Generation Insulin Delivery Optimization Platform

A futuristic, adaptive insulin delivery system leveraging machine learning, real-time glucose data, and personalized insulin sensitivity profiles to revolutionize diabetes management.

The original patent addressed adjusting insulin delivery rates based on user input and glucose data. However, it had limitations in terms of adaptability, personalization, and real-time feedback. The new inventive concept overcomes these limitations by integrating machine learning algorithms, predictive analytics, and real-time glucose data feedback to create a more accurate, personalized, and adaptive insulin delivery system.

The next-generation insulin delivery optimization platform consists of a wearable device, a cloud-based data repository, and a machine learning module. The wearable device tracks glucose levels and sends data to the cloud-based repository. The machine learning module generates personalized insulin sensitivity profiles and predictive models of future glucose values. A recommendation engine selects a basal insulin delivery profile that minimizes differences between predicted future glucose values and a target glucose level. The system adaptively adjusts the selected basal insulin delivery profile based on real-time glucose data feedback and user input.

The new inventive concept introduces a paradigm shift in insulin delivery optimization by integrating machine learning, real-time glucose data, and personalized insulin sensitivity profiles. This approach enables a more accurate, personalized, and adaptive insulin delivery system that surpasses the limitations of the original patent.

Alternative embodiments of the inventive concept could include variations in the wearable device's design, the type of machine learning algorithms used, or the integration of additional health metrics. These variations could be implemented to cater to different user needs, preferences, or medical conditions.

The next-generation insulin delivery optimization platform has vast commercial potential in the diabetes management industry, with potential applications in wearable devices, cloud-based health platforms, and personalized medicine. The target market includes individuals with diabetes, healthcare providers, and pharmaceutical companies.